| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 22.05.
| Too Little, Too Late for Achillion? | | 1 | Motley Fool |
| 21.05.
| Achillion jumps on hepatitis C study | | 2 | MarketWatch |
| 16.05.
| Achillion gains FDA fast track designation for NS5A inhibitor against HCV | | 1 | Pharma Bus Review |
| 15.05.
| UPDATE 1- Achillion's hepatitis C drug gets FDA fast track | | 1 | Reuters.com |
| 07.05.
| UBS stuft Achillion Pharma von sell auf neutral. | | 40 | BörseGo |
| UBS stuft Achillion Pharma von sell auf neutral.
(© BörseGo AG 2012 - Autor: Tobias Krieg, Redakteur)
Mehr lesen zu:
UBS stuft Achillion Pharma von sell auf neutral. | |
| 24.04.
| Pharmaceutical Companies Look to Biotech Industry to Combat Losses from Expiring Patents / The Paragon Report Provides Stock Research on Achillion Pharmaceuticals and Keryx Biopharmaceuticals | | 29 | MarketWire |
| NEW YORK, NY -- (Marketwire) -- 04/24/12 -- Mergers and Acquisitions have been a hot topic in the Biotechnology Industry recently. Pharmaceutical giants face an unprecedented number of patent expirations...
Mehr lesen zu:
Pharmaceutical Companies Look to Biotech Industry to Combat Losses from Expiring Patents / The Paragon Report Provides Stock Research on Achillion Pharmaceuticals and Keryx Biopharmaceuticals | |
| 23.04.
| Achillion Clarifies End of Treatment Data From Phase 2a Trial With ACH-1625 Based Regimen in Hepatitis C | | 3 | Benzinga.com |
| 23.04.
| Achillion (ACHN) Updates on EQT Data from Segment 2 of ACH-1625 Phase 2a | | 2 | StreetInsider.com |
| 23.04.
| Achillion (ACHN) Presents Strong Data from ACH-1625 Phase 2a; Safety Profile Similar | | 3 | StreetInsider.com |
| 21.04.
| Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C | | 2 | Benzinga.com |
| 19.04.
| Notable Options Activity in Achillion Pharmaceuticals, Inc. | | 3 | Benzinga.com |
| 19.04.
| Achillion (ACHN) Shares Slammed, Gilead (GILD), Idenix (IDIX) Rip on New HCV Treatment Data | | 7 | StreetInsider.com |
| 08.03.
| ACHILLION PHARMACEUTICALS INC - 10-K, Annual Report | | 2 | SEC Filings |
| 22.02.
| 2012 Economic Outlook - Report Highlights Achillion Pharmaceuticals, Inc. and Fusion-IO, Inc. | | 17 | MarketWire |
| HONG KONG -- (Marketwire) -- 02/22/12 -- Today, www.BrightonMarkets.com announced new reports highlighting Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) and Fusion-IO, Inc. (NYSE: FIO). Gain market...
Mehr lesen zu:
2012 Economic Outlook - Report Highlights Achillion Pharmaceuticals, Inc. and Fusion-IO, Inc. | |
| 13.01.
| A Forward Look, the Year Ahead -- Featured Research on Achillion Pharmaceuticals, Inc. and Nektar Therapeutics | | 38 | MarketWire |
| HONG KONG -- (Marketwire) -- 01/13/12 -- Today, www.BollingerReport.com introduced featured coverage of Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) and Nektar Therapeutics (NASDAQ: NKTR). Full...
Mehr lesen zu:
A Forward Look, the Year Ahead -- Featured Research on Achillion Pharmaceuticals, Inc. and Nektar Therapeutics | |
| 09.01.
| Achillion Pharma (ACHN) Plans Further Development of ACH-1625 as HCV Treatment | | 9 | StreetInsider.com |
| 04.01.
| UPDATE 1-Achillion's hepatitis C drug gets FDA fast track | | 3 | Reuters.com |
| 04.01.
| Achillion (ACHN) Gets Fast Track Designation from FDA for ACH-1625 for Treatment of Chronic Hepatitis C | | 2 | StreetInsider.com |
| 14.12.
| Zacks.com featured expert Kevin Matras highlights: Ulta Salon, Cosmetics & Fragrance, Inc., Hexcel Corp., On Assignment, Inc., Advance America, Cash Advance Centers, Inc. and Achillion Pharmaceuticals, Inc. | | 40 | PR Newswire |
| CHICAGO, Dec. 14, 2011 /PRNewswire/ -- Stocks in this week's article include Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ: ULTA), Hexcel Corp. (NYSE: HXL), On Assignment, Inc. (NASDAQ: ASGN), Advance...
Mehr lesen zu:
Zacks.com featured expert Kevin Matras highlights: Ulta Salon, Cosmetics & Fragrance, Inc., Hexcel Corp., On Assignment, Inc., Advance America, Cash Advance Centers, Inc. and Achillion Pharmaceuticals, Inc. | |
| 05.12.
| Roth Adds Achillion Pharma (ACHN) to 'Focus List' | | 3 | StreetInsider.com |
